Pharma Focus Asia

Galmed Pharma Data Demonstrates Significant Reduction of Inflammation

Thursday, March 31, 2016

Galmed Pharmaceuticals Pre-Clinical data demonstrating significant anti-fibrotic activity of Aramchol in Methionine and choline deficient diet in mice.

Studies showed both statistically significant reduction of inflammation and statically significant effect on liver fibrosis.

 

Source : reuters.com

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024